Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma

[1]  A. Petrilli,et al.  Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  G. Fontanini,et al.  Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer , 2005, British Journal of Cancer.

[3]  Kurt D. Hankenson,et al.  Mice with a Disruption of the Thrombospondin 3 Gene Differ in Geometric and Biomechanical Properties of Bone and Have Accelerated Development of the Femoral Head , 2005, Molecular and Cellular Biology.

[4]  S Hsueh,et al.  Overexpression of SPARC gene in human gastric carcinoma and its clinic–pathologic significance , 2004, British Journal of Cancer.

[5]  M. Guzmán,et al.  Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas , 2004, Cancer Research.

[6]  Qing‐Yu He,et al.  Application of Proteomics in the Study of Tumor Metastasis , 2004, Genomics, proteomics & bioinformatics.

[7]  S. Cheung,et al.  Clinical Significance of Thrombospondin 1 Expression in Hepatocellular Carcinoma , 2004, Clinical Cancer Research.

[8]  J. Rutka,et al.  International Hermelin brain tumor symposium on matricellular proteins in normal and cancer cell-matrix interactions. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[9]  N. Welsh,et al.  In vitro cultured rat islets express genes that both prevent and promote angiogenesis. , 2004, JOP : Journal of the pancreas.

[10]  R. Gorlick,et al.  Osteosarcoma necrosis following chemotherapy: innate biology versus treatment-specific. , 2003, Journal of pediatric hematology/oncology.

[11]  D. Guidolin,et al.  Endothelial cells in the bone marrow of patients with multiple myeloma. , 2003, Blood.

[12]  H. Hsu,et al.  Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma , 2003, Cancer.

[13]  M. Mori,et al.  Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression , 2003, Cancer.

[14]  O. Volpert,et al.  SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis. , 2002, Cancer research.

[15]  P. Bornstein,et al.  Matricellular proteins: extracellular modulators of cell function. , 2002, Current opinion in cell biology.

[16]  C. Iacobuzio-Donahue,et al.  The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. , 2002, Cancer research.

[17]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[18]  K. Trieb,et al.  The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter. , 2002, Journal of clinical pathology.

[19]  Alan Cantor,et al.  Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. , 2002, Journal of the National Cancer Institute.

[20]  K. Kelly,et al.  Chemokine Expression Patterns Differ within Anatomically Distinct Regions of the Genital Tract during Chlamydia trachomatis Infection , 2002, Infection and Immunity.

[21]  M. Ringuette,et al.  Novel Functions of the Matricellular Proteins Osteopontin and Osteonectin/SPARC , 2002, Connective tissue research.

[22]  G. Weber.  The metastasis gene osteopontin: a candidate target for cancer therapy. , 2001, Biochimica et biophysica acta.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  W. Lubitz,et al.  P700: the primary electron donor of photosystem I. , 2001, Biochimica et biophysica acta.

[25]  L. Akslen,et al.  Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas. , 2001, The American journal of pathology.

[26]  E. Sage,et al.  SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.

[27]  P. Meltzer,et al.  Metastasis-associated differences in gene expression in a murine model of osteosarcoma. , 2001, Cancer research.

[28]  P. Malfertheiner,et al.  Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density , 2001, Virchows Archiv.

[29]  A. O’Regan,et al.  Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation , 2000, International journal of experimental pathology.

[30]  M. Iruela-Arispe,et al.  Cell Contact–dependent Activation of α3β1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1 , 2000 .

[31]  E. Sage,et al.  SPARC, a Matricellular Glycoprotein with Important Biological Functions , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  D. Massi,et al.  Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. , 1999, Human pathology.

[33]  S. Groshen,et al.  Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. , 1997, Journal of the National Cancer Institute.

[34]  G. Tuszynski,et al.  Expression of Thrombospondin-1 in Cancer: A Role in Tumor Progression , 1996, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[35]  R. Berkowitz,et al.  SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. , 1996, Oncogene.

[36]  T. Wada,et al.  A preliminary report of neoadjuvant chemotherapy NSH-7 study in osteosarcoma: preoperative salvage chemotherapy based on clinical tumor response and the use of granulocyte colony-stimulating factor. , 1996, Oncology.

[37]  I. James,et al.  Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[38]  Ronald W. Davis,et al.  Quantitative Monitoring of Gene Expression Patterns with a Complementary DNA Microarray , 1995, Science.

[39]  E. Manseau,et al.  Osteopontin expression and distribution in human carcinomas. , 1994, The American journal of pathology.

[40]  R. Dodds,et al.  Expression of osteopontin mRNA by osteoclasts and osteoblasts in modelling adult human bone. , 1993, Journal of cell science.

[41]  Josephine C. Adams,et al.  The thrombospondin family , 1993, Current Biology.

[42]  A. Schulz,et al.  Osteonectin — a differentiation marker of bone cells , 1987, Cell and Tissue Research.

[43]  H. Kleinman,et al.  Osteonectin, a bone-specific protein linking mineral to collagen , 1981, Cell.

[44]  Daphne Vassiliou,et al.  Differential expression of osteopontin and bone sialoprotein in bone metastasis of breast and prostate carcinoma , 2004, Clinical & Experimental Metastasis.

[45]  M. Iruela-Arispe,et al.  Cell contact-dependent activation of alpha3beta1 integrin modulates endothelial cell responses to thrombospondin-1. , 2000, Molecular biology of the cell.

[46]  C. Angeletti,et al.  Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  M. Noda,et al.  Osteopontin expression and function: Role in bone remodeling , 1998, Journal of cellular biochemistry. Supplement.

[48]  J. Lawler,et al.  Extracellular matrix: the thrombospondin family. , 1993, Current biology : CB.

[49]  G. Rodan,et al.  Gene expression in osteoblastic cells. , 1991, Critical reviews in eukaryotic gene expression.